← All trials
NCT06816914
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 5, 2025
- Primary completion
- Feb 5, 2027
- Completion date
- Feb 5, 2028
- First posted
- Feb 10, 2025
- Last posted
- Feb 20, 2025
- Enrollment
- 84
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Taichung Veterans General HospitalLead sponsor
- Government of TaiwanCollaborator
- Taichung Veterans General HospitalSponsor investigator
- Chang Gung UniversityCollaborator
- Taipei Veteran General hospitalCollaborator
- China Medical UniversityCollaborator
- Kaohsiung Medical UniversityCollaborator
- National Cheng Kung UniversityCollaborator
- National Taiwan UniversityCollaborator
- National Cheng Kung UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.